Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Spruce Biosciences to Present at Upcoming Investor Conferences in March

businesswire.com
SPRB The article announces that Spruce Biosciences will present at investor conferences. This is a routine corporate event and does not provide specific information about the company's performance or prospects, hence the neutral sentiment.

Spruce Biosciences to Present at Upcoming Investor Conferences in March SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at two upcoming investor conferences taking place in March.

Interested parties can access the live webcasts for each conference on the events section of the Company’s website. An archived copy of the webcasts will be available for approximately 90 days.

About Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need. To learn more, visit www.sprucebio.com and follow us on X, LinkedIn, Facebook and YouTube.